Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Genome-wide Control of Heterochromatin Replication by the Telomere Capping Protein TRF2.

Mendez-Bermudez A, Lototska L, Bauwens S, Giraud-Panis MJ, Croce O, Jamet K, Irizar A, Mowinckel M, Koundrioukoff S, Nottet N, Almouzni G, Teulade-Fichou MP, Schertzer M, Perderiset M, Londoño-Vallejo A, Debatisse M, Gilson E, Ye J.

Mol Cell. 2018 May 3;70(3):449-461.e5. doi: 10.1016/j.molcel.2018.03.036.

2.

TRFH domain: at the root of telomere protein evolution?

Giraud-Panis MJ, Ye J, Gilson E.

Cell Res. 2018 Jan;28(1):7-8. doi: 10.1038/cr.2017.152. Epub 2017 Dec 1.

3.

Dynamics under the Telomeric Bridge.

Pisano S, Gilson E, Giraud-Panis MJ.

Mol Cell. 2017 Nov 16;68(4):643-644. doi: 10.1016/j.molcel.2017.11.005. Review.

4.

ERK1/2/MAPK pathway-dependent regulation of the telomeric factor TRF2.

Picco V, Coste I, Giraud-Panis MJ, Renno T, Gilson E, Pagès G.

Oncotarget. 2016 Jul 19;7(29):46615-46627. doi: 10.18632/oncotarget.10316.

5.

TRF2-Mediated Control of Telomere DNA Topology as a Mechanism for Chromosome-End Protection.

Benarroch-Popivker D, Pisano S, Mendez-Bermudez A, Lototska L, Kaur P, Bauwens S, Djerbi N, Latrick CM, Fraisier V, Pei B, Gay A, Jaune E, Foucher K, Cherfils-Vicini J, Aeby E, Miron S, Londoño-Vallejo A, Ye J, Le Du MH, Wang H, Gilson E, Giraud-Panis MJ.

Mol Cell. 2016 Jan 21;61(2):274-86. doi: 10.1016/j.molcel.2015.12.009. Epub 2016 Jan 7.

6.

A higher-order entity formed by the flexible assembly of RAP1 with TRF2.

Gaullier G, Miron S, Pisano S, Buisson R, Le Bihan YV, Tellier-Lebègue C, Messaoud W, Roblin P, Guimarães BG, Thai R, Giraud-Panis MJ, Gilson E, Le Du MH.

Nucleic Acids Res. 2016 Feb 29;44(4):1962-76. doi: 10.1093/nar/gkv1531. Epub 2016 Jan 8.

7.

TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization.

Galati A, Micheli E, Alicata C, Ingegnere T, Cicconi A, Pusch MC, Giraud-Panis MJ, Gilson E, Cacchione S.

Nucleic Acids Res. 2015 Jul 13;43(12):5824-37. doi: 10.1093/nar/gkv507. Epub 2015 May 20.

8.

The basic N-terminal domain of TRF2 limits recombination endonuclease action at human telomeres.

Saint-Léger A, Koelblen M, Civitelli L, Bah A, Djerbi N, Giraud-Panis MJ, Londoño-Vallejo A, Ascenzioni F, Gilson E.

Cell Cycle. 2014;13(15):2469-74. doi: 10.4161/cc.29422.

9.

The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter.

El Maï M, Wagner KD, Michiels JF, Ambrosetti D, Borderie A, Destree S, Renault V, Djerbi N, Giraud-Panis MJ, Gilson E, Wagner N.

Cell Rep. 2014 Nov 6;9(3):1047-60. doi: 10.1016/j.celrep.2014.09.038. Epub 2014 Oct 23.

10.

Effect of Rap1 binding on DNA distortion and potassium permanganate hypersensitivity.

Le Bihan YV, Matot B, Pietrement O, Giraud-Panis MJ, Gasparini S, Le Cam E, Gilson E, Sclavi B, Miron S, Le Du MH.

Acta Crystallogr D Biol Crystallogr. 2013 Mar;69(Pt 3):409-19. doi: 10.1107/S0907444912049311. Epub 2013 Feb 16.

PMID:
23519416
11.

One identity or more for telomeres?

Giraud-Panis MJ, Pisano S, Benarroch-Popivker D, Pei B, Le Du MH, Gilson E.

Front Oncol. 2013 Mar 15;3:48. doi: 10.3389/fonc.2013.00048. eCollection 2013.

12.

TRF2 controls telomeric nucleosome organization in a cell cycle phase-dependent manner.

Galati A, Magdinier F, Colasanti V, Bauwens S, Pinte S, Ricordy R, Giraud-Panis MJ, Pusch MC, Savino M, Cacchione S, Gilson E.

PLoS One. 2012;7(4):e34386. doi: 10.1371/journal.pone.0034386. Epub 2012 Apr 20.

13.

The N-terminal domains of TRF1 and TRF2 regulate their ability to condense telomeric DNA.

Poulet A, Pisano S, Faivre-Moskalenko C, Pei B, Tauran Y, Haftek-Terreau Z, Brunet F, Le Bihan YV, Ledu MH, Montel F, Hugo N, Amiard S, Argoul F, Chaboud A, Gilson E, Giraud-Panis MJ.

Nucleic Acids Res. 2012 Mar;40(6):2566-76. doi: 10.1093/nar/gkr1116. Epub 2011 Dec 1.

14.

CST meets shelterin to keep telomeres in check.

Giraud-Panis MJ, Teixeira MT, Géli V, Gilson E.

Mol Cell. 2010 Sep 10;39(5):665-76. doi: 10.1016/j.molcel.2010.08.024. Review.

15.

Structural identity of telomeric complexes.

Giraud-Panis MJ, Pisano S, Poulet A, Le Du MH, Gilson E.

FEBS Lett. 2010 Sep 10;584(17):3785-99. doi: 10.1016/j.febslet.2010.08.004. Epub 2010 Aug 7. Review.

16.

TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage.

Ye J, Lenain C, Bauwens S, Rizzo A, Saint-Léger A, Poulet A, Benarroch D, Magdinier F, Morere J, Amiard S, Verhoeyen E, Britton S, Calsou P, Salles B, Bizard A, Nadal M, Salvati E, Sabatier L, Wu Y, Biroccio A, Londoño-Vallejo A, Giraud-Panis MJ, Gilson E.

Cell. 2010 Jul 23;142(2):230-42. doi: 10.1016/j.cell.2010.05.032.

17.

SNMIB/Apollo protects leading-strand telomeres against NHEJ-mediated repair.

Lam YC, Akhter S, Gu P, Ye J, Poulet A, Giraud-Panis MJ, Bailey SM, Gilson E, Legerski RJ, Chang S.

EMBO J. 2010 Jul 7;29(13):2230-41. doi: 10.1038/emboj.2010.58. Epub 2010 Jun 15.

18.

TRF2/RAP1 and DNA-PK mediate a double protection against joining at telomeric ends.

Bombarde O, Boby C, Gomez D, Frit P, Giraud-Panis MJ, Gilson E, Salles B, Calsou P.

EMBO J. 2010 May 5;29(9):1573-84. doi: 10.1038/emboj.2010.49. Epub 2010 Apr 20.

19.

Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.

Ourliac-Garnier I, Poulet A, Charif R, Amiard S, Magdinier F, Rezaï K, Gilson E, Giraud-Panis MJ, Bombard S.

J Biol Inorg Chem. 2010 Jun;15(5):641-54. doi: 10.1007/s00775-010-0631-4. Epub 2010 Feb 27.

PMID:
20191372
20.

TRF2 promotes, remodels and protects telomeric Holliday junctions.

Poulet A, Buisson R, Faivre-Moskalenko C, Koelblen M, Amiard S, Montel F, Cuesta-Lopez S, Bornet O, Guerlesquin F, Godet T, Moukhtar J, Argoul F, Déclais AC, Lilley DM, Ip SC, West SC, Gilson E, Giraud-Panis MJ.

EMBO J. 2009 Mar 18;28(6):641-51. doi: 10.1038/emboj.2009.11. Epub 2009 Feb 5.

21.

Topoisomerase IIIalpha is required for normal proliferation and telomere stability in alternative lengthening of telomeres.

Temime-Smaali N, Guittat L, Wenner T, Bayart E, Douarre C, Gomez D, Giraud-Panis MJ, Londono-Vallejo A, Gilson E, Amor-Guéret M, Riou JF.

EMBO J. 2008 May 21;27(10):1513-24. doi: 10.1038/emboj.2008.74. Epub 2008 Apr 17.

22.

A topological mechanism for TRF2-enhanced strand invasion.

Amiard S, Doudeau M, Pinte S, Poulet A, Lenain C, Faivre-Moskalenko C, Angelov D, Hug N, Vindigni A, Bouvet P, Paoletti J, Gilson E, Giraud-Panis MJ.

Nat Struct Mol Biol. 2007 Feb;14(2):147-54. Epub 2007 Jan 14.

PMID:
17220898
23.

Nucleic acid structure and recognition.

Duckett DR, Murchie AI, Clegg RM, Bassi GS, Giraud-Panis MJ, Lilley DM.

Biophys Chem. 1997 Oct;68(1-3):53-62.

PMID:
17029905
24.

The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.

Gomez D, O'Donohue MF, Wenner T, Douarre C, Macadré J, Koebel P, Giraud-Panis MJ, Kaplan H, Kolkes A, Shin-ya K, Riou JF.

Cancer Res. 2006 Jul 15;66(14):6908-12.

25.

The Apollo 5' exonuclease functions together with TRF2 to protect telomeres from DNA repair.

Lenain C, Bauwens S, Amiard S, Brunori M, Giraud-Panis MJ, Gilson E.

Curr Biol. 2006 Jul 11;16(13):1303-10. Epub 2006 May 25.

26.

Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways.

Sedletska Y, Giraud-Panis MJ, Malinge JM.

Curr Med Chem Anticancer Agents. 2005 May;5(3):251-65. Review.

PMID:
15992353
27.

Functional interaction between poly(ADP-Ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively regulates TRF2.

Dantzer F, Giraud-Panis MJ, Jaco I, Amé JC, Schultz I, Blasco M, Koering CE, Gilson E, Ménissier-de Murcia J, de Murcia G, Schreiber V.

Mol Cell Biol. 2004 Feb;24(4):1595-607.

28.

Drosophila DSP1 and rat HMGB1 have equivalent DNA binding properties and share a similar secondary fold.

Janke C, Martin D, Giraud-Panis MJ, Decoville M, Locker D.

J Biochem. 2003 Apr;133(4):533-9.

29.

Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.

Leng M, Locker D, Giraud-Panis MJ, Schwartz A, Intini FP, Natile G, Pisano C, Boccarelli A, Giordano D, Coluccia M.

Mol Pharmacol. 2000 Dec;58(6):1525-35.

PMID:
11093793
30.

Transplatin-modified oligonucleotides as modulators of gene expression.

Giraud-Panis M, Leng M.

Pharmacol Ther. 2000 Mar;85(3):175-81. Review.

PMID:
10739872
31.

Interstrand cross-links of cisplatin induce striking distortions in DNA.

Malinge JM, Giraud-Panis MJ, Leng M.

J Inorg Biochem. 1999 Oct;77(1-2):23-9. Review.

PMID:
10626349
32.

HMG boxes of DSP1 protein interact with the rel homology domain of transcription factors.

Decoville M, Giraud-Panis MJ, Mosrin-Huaman C, Leng M, Locker D.

Nucleic Acids Res. 2000 Jan 15;28(2):454-62.

33.

Structural recognition and distortion by the DNA junction-resolving enzyme RusA.

Giraud-Panis MJ, Lilley DM.

J Mol Biol. 1998 Apr 24;278(1):117-33.

PMID:
9571038
34.

T4 endonuclease VII--a zinc containing four-way DNA junction resolving enzyme.

Giraud-Panis MJ, Pöhler JR, Lilley DM.

Biochem Soc Trans. 1997 Nov;25(4):S644. No abstract available.

PMID:
9450072
35.

Recognition and manipulation of branched DNA structure by junction-resolving enzymes.

White MF, Giraud-Panis MJ, Pöhler JR, Lilley DM.

J Mol Biol. 1997 Jun 27;269(5):647-64. Review.

PMID:
9223630
36.
37.

T4 endonuclease VII. Importance of a histidine-aspartate cluster within the zinc-binding domain.

Giraud-Panis MJ, Lilley DM.

J Biol Chem. 1996 Dec 20;271(51):33148-55.

38.
39.

The modular character of a DNA junction-resolving enzyme: a zinc-binding motif in bacteriophage T4 endonuclease VII.

Giraud-Panis MJ, Duckett DR, Lilley DM.

J Mol Biol. 1995 Oct 6;252(5):596-610.

PMID:
7563077
40.

Structure of the four-way DNA junction and its interaction with proteins.

Duckett DR, Murchie AI, Giraud-Panis MJ, Pöhler JR, Lilley DM.

Philos Trans R Soc Lond B Biol Sci. 1995 Jan 30;347(1319):27-36. Review.

PMID:
7746850
41.

Fluorescence study on the non-specific binding of cyclic-AMP receptor protein to DNA: effect of pH.

Giraud-Panis MJ, Toulmé F, Blazy B, Maurizot JC, Culard F.

Biochimie. 1994;76(2):133-9.

PMID:
8043649
42.

Specific binding of cyclic-AMP receptor protein to DNA. Effect of the sequence and of the introduction of a nick in the binding site.

Giraud-Panis MJ, Toulmé F, Maurizot JC, Culard F.

J Biomol Struct Dyn. 1992 Oct;10(2):295-309.

PMID:
1334673

Supplemental Content

Loading ...
Support Center